Page last updated: 2024-08-17

levodopa and cannabidiol

levodopa has been researched along with cannabidiol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Consroe, P; Sandyk, R; Snider, SR1
da-Silva, CA; Del-Bel, E; Dos-Santos-Pereira, M; GuimarĂ£es, FS1
Del Bel, E; Dos-Santos-Pereira, M; GuimarĂ£es, FS; Junior, NCF1

Reviews

1 review(s) available for levodopa and cannabidiol

ArticleYear
Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.
    Neurotoxicity research, 2020, Volume: 37, Issue:1

    Topics: Animals; Cannabidiol; Cannabinoids; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease

2020

Other Studies

3 other study(ies) available for levodopa and cannabidiol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Open label evaluation of cannabidiol in dystonic movement disorders.
    The International journal of neuroscience, 1986, Volume: 30, Issue:4

    Topics: Adult; Aged; Cannabidiol; Cannabinoids; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Levodopa; Male; Meige Syndrome; Middle Aged; Muscle Spasticity; Torticollis

1986
Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action.
    Neurobiology of disease, 2016, Volume: 94

    Topics: Animals; Anti-Dyskinesia Agents; Arachidonic Acids; Brain; Cannabidiol; Capsaicin; Cyclooxygenase 2; Dyskinesia, Drug-Induced; Endocannabinoids; Extracellular Signal-Regulated MAP Kinases; Histones; Levodopa; Male; Mice, Inbred C57BL; NF-kappa B; Oxidopamine; Parkinsonian Disorders; Polyunsaturated Alkamides; PPAR gamma; Receptor, Cannabinoid, CB1; TRPV Cation Channels; Tyrosine 3-Monooxygenase

2016